NO20026029L - Indolderivater nyttige for behandlingen av CNS-forstyrrelser - Google Patents

Indolderivater nyttige for behandlingen av CNS-forstyrrelser

Info

Publication number
NO20026029L
NO20026029L NO20026029A NO20026029A NO20026029L NO 20026029 L NO20026029 L NO 20026029L NO 20026029 A NO20026029 A NO 20026029A NO 20026029 A NO20026029 A NO 20026029A NO 20026029 L NO20026029 L NO 20026029L
Authority
NO
Norway
Prior art keywords
treatment
cns disorders
indole derivatives
derivatives useful
useful
Prior art date
Application number
NO20026029A
Other languages
English (en)
Norwegian (no)
Other versions
NO20026029D0 (no
Inventor
Benny Bang-Andersen
Jakob Felding
Jan Kehler
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20026029D0 publication Critical patent/NO20026029D0/no
Publication of NO20026029L publication Critical patent/NO20026029L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20026029A 2000-06-29 2002-12-16 Indolderivater nyttige for behandlingen av CNS-forstyrrelser NO20026029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001018 2000-06-29
PCT/DK2001/000407 WO2002000645A1 (en) 2000-06-29 2001-06-13 Indole derivatives useful for the treatment of cns disorders

Publications (2)

Publication Number Publication Date
NO20026029D0 NO20026029D0 (no) 2002-12-16
NO20026029L true NO20026029L (no) 2002-12-16

Family

ID=8159589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026029A NO20026029L (no) 2000-06-29 2002-12-16 Indolderivater nyttige for behandlingen av CNS-forstyrrelser

Country Status (23)

Country Link
US (1) US20030232822A1 (pl)
EP (1) EP1299380B1 (pl)
JP (1) JP2004501912A (pl)
KR (1) KR20030011365A (pl)
CN (1) CN1439004A (pl)
AR (1) AR028736A1 (pl)
AT (1) ATE268765T1 (pl)
AU (1) AU2001273882A1 (pl)
BG (1) BG107471A (pl)
BR (1) BR0112286A (pl)
CA (1) CA2414115A1 (pl)
CZ (1) CZ20024192A3 (pl)
DE (1) DE60103761D1 (pl)
EA (1) EA200300084A1 (pl)
HU (1) HUP0300786A2 (pl)
IL (1) IL153254A0 (pl)
IS (1) IS6642A (pl)
MX (1) MXPA02012506A (pl)
NO (1) NO20026029L (pl)
PL (1) PL358966A1 (pl)
SK (1) SK1092003A3 (pl)
WO (1) WO2002000645A1 (pl)
ZA (1) ZA200209886B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
AU2003257407A1 (en) * 2002-08-29 2004-03-19 H. Lundbeck A/S S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
DE102004027358A1 (de) * 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
EP2049120A4 (en) * 2006-07-31 2011-09-07 Janssen Pharmaceutica Nv UROTENSIN II RECEPTOR ANTAGONISTS
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider
FR2953839A1 (fr) * 2009-12-14 2011-06-17 Sanofi Aventis Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL310443A1 (en) * 1993-03-01 1995-12-11 Merck Sharp & Dohme Derivatives of pyrolo-pyridine
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
AR028736A1 (es) 2003-05-21
HUP0300786A2 (hu) 2003-07-28
CZ20024192A3 (cs) 2003-04-16
EA200300084A1 (ru) 2003-06-26
CA2414115A1 (en) 2002-01-03
US20030232822A1 (en) 2003-12-18
MXPA02012506A (es) 2003-04-25
SK1092003A3 (en) 2003-05-02
EP1299380B1 (en) 2004-06-09
ZA200209886B (en) 2003-12-05
AU2001273882A1 (en) 2002-01-08
WO2002000645A1 (en) 2002-01-03
ATE268765T1 (de) 2004-06-15
EP1299380A1 (en) 2003-04-09
JP2004501912A (ja) 2004-01-22
DE60103761D1 (de) 2004-07-15
IL153254A0 (en) 2003-07-06
NO20026029D0 (no) 2002-12-16
BG107471A (en) 2003-10-31
BR0112286A (pt) 2003-05-13
PL358966A1 (pl) 2004-08-23
KR20030011365A (ko) 2003-02-07
IS6642A (is) 2002-11-29
CN1439004A (zh) 2003-08-27

Similar Documents

Publication Publication Date Title
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20032801D0 (no) Tiazolderivater for behandling av PPAR relaterte forstyrrelser
NO20014047D0 (no) Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser
NO993051D0 (no) Intranasale formuleringer for behandling av seksuelle forstyrrelser
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
DK1165510T3 (da) 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
NO20026005L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
HRP20030052A2 (en) 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
NO20030127L (no) Indolderivater nyttige for behandling av CNS-forstyrrelser
NO20011892L (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO20026029D0 (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20026028L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO993948D0 (no) Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser
IL153234A0 (en) Indole derivatives useful for the treatment of cns disorders
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1309586T1 (sl) Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns
NO20011189L (no) Innretning for behandling av suspensjoner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application